BIOCORRX NEW (BICX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 81 125 sessions, September 30, 2025 to October 1, 2026
- Largest daily move
- +95.7% close of December 19, 2025
- 1-year change
- +0% closing prices, September 30, 2025 to October 1, 2026
- 1-month change
- +1% closing prices, August 31, 2026 to October 1, 2026
Company Description
BIOCORRX NEW (OTC: BICX) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $6.3M.
BICX has gained 0.0% over the past year. The last closing price was $0.2120.
For FY2025, BIOCORRX NEW reported revenue of $797K with net income of -$3.4M and diluted earnings per share of -$0.19. The company operates at a net profit margin of -431.5%.
This page collects what Stock Titan holds for BICX, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
BIOCORRX NEW (BICX) closed at $0.2120 on October 1, 2026. Over the past 12 months, the price has gained 0.0%.
BICX Metrics & Rankings
Price returns through October 1, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BIOCORRX NEW has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include management, fda approval, clinical trial. View all BICX news →
SEC Filings
BIOCORRX NEW has filed 6 recent SEC filings, including 3 Form 10-Q, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on September 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BICX SEC filings →
Financial Highlights
BIOCORRX NEW generated $797K in revenue in FY2025, operating income reached -$4.8M (-606.0% operating margin), and net income was -$3.4M, reflecting a -431.5% net profit margin. Diluted earnings per share stood at -$0.19. The company generated -$2.3M in operating cash flow. The current ratio was 0.10, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in BIOCORRX NEW (BICX) currently stands at 10.1 thousand shares, down 44.3% from the previous reporting period, representing 0.1% of the float. Since October 2025, short interest has increased by 16705.0%.
Days to Cover History
Days to cover for BIOCORRX NEW (BICX) currently stands at 4.0 days, up 89.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 304%. Across the settlements charted above, it has ranged from 1.0 to 127.8 days.
BICX Company Profile & Sector Positioning
BIOCORRX NEW (BICX) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BICX often look at related companies in the same sector, including VELTEX CORP (VLXC), XCELERATE INC (XCRT), AESTHETIC MEDICAL (PAIYY), NUMINUS WELLNESS INC (NUMIF), and SELECTIS HEALTH INC (GBCS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BICX's relative position within its industry.